Definitive Healthcare Corp. filings document the regulatory disclosures of a public healthcare data and analytics software company. Recent Form 8-K reports furnish quarterly and annual financial-result releases covering revenue, net loss, adjusted profitability measures, cash flow, guidance, and impairment-related disclosures tied to the company’s subscription-based commercial intelligence platform.
The filing record also includes definitive proxy materials for annual stockholder matters, board elections, executive compensation, equity awards, and governance practices. Other material-event filings document board and committee composition changes, executive-role and compensation arrangements, and the termination of a nominating agreement affecting director-designation rights.
Definitive Healthcare Corp. (DH) reported a filing action. The company furnished an Item 2.02 Form 8‑K to announce it issued a press release with financial results for the third quarter ended September 30, 2025. The press release is included as Exhibit 99.1. The company states the information in Item 2.02 and Exhibit 99.1 is being furnished, not filed, and is not subject to Section 18 liabilities nor incorporated by reference into other filings.
Definitive Healthcare Corp. (DH) disclosed an insider transaction by its Chief Financial Officer on a Form 4. On 11/01/2025, the CFO had 1,244 shares of Class A common stock withheld at $2.77 per share under transaction code F, which indicates shares were withheld to cover taxes on vested restricted stock units. Following this administrative withholding, the officer beneficially owns 1,080,177 shares directly. The footnote confirms the activity was tied to the vesting and settlement of previously reported RSUs.
Definitive Healthcare (DH) reported an insider transaction by its Executive Chairman and Director. On 11/01/2025, 18,796 shares of Class A common stock were withheld by the company at $2.77 per share to cover tax obligations upon the vesting and settlement of previously reported RSUs. Following this administrative transaction, the reporting person beneficially owns 1,060,584 shares directly and 450,000 shares indirectly through DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which he is the beneficiary.
Definitive Healthcare Corp. reporting person Casey Heller, the company's Chief Financial Officer, disclosed a transaction on 10/01/2025 in which 8,300 shares of Class A common stock were disposed of at $3.56 per share. After the reported sale, the filing shows the reporting person beneficially owns 1,081,421 shares. The form explains the transaction reflects shares withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. The filing is an individual Form 4 and was signed by an attorney-in-fact on behalf of the reporting person.
Kevin Coop, who is listed as both Chief Executive Officer and a Director of Definitive Healthcare Corp. (DH), reported a transaction on 10/01/2025. The report shows a Code F(1) transaction disposing of 37,593 shares of Class A common stock at a price of $3.56 per share. The filing explains these shares were withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. After the withholding, the reporting person beneficially owned 3,584,788 shares, held directly. The form is signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025.
Definitive Healthcare Corp. (DH) insider Jason R. Krantz reported a transaction on 09/14/2025. The filing shows a disposition of 4,093 shares of Class A common stock at $4.15 per share, recorded as a sale to satisfy tax withholding related to vested restricted stock units. After the transaction, Mr. Krantz directly beneficially owns 1,079,380 shares and indirectly owns 450,000 shares held in trust by DH Holdings (formerly the Jason R. Krantz 2009 Trust). The filing was signed by an attorney-in-fact on 09/16/2025.
On 08/01/2025, Definitive Healthcare Corp. (DH) Chief Financial Officer Casey Heller filed a Form 4 reporting a routine tax-withholding transaction. The company withheld 1,244 Class A common shares (transaction code F) at an implied price of $3.74 per share to cover federal taxes triggered by the vesting of previously granted restricted stock units. Following the withholding, Heller still directly owns 1,089,721 shares, preserving the vast majority of his stake. No open-market purchase or discretionary sale occurred, and there were no derivative security movements disclosed. The filing is administrative in nature and does not indicate a change in role, outlook, or insider sentiment.
Form 4 filed 08/05/2025 discloses that Definitive Healthcare (DH) Chief Operating Officer Kate Marie Shamsuddin satisfied tax-withholding obligations from previously granted restricted stock units. On 08/01/2025 she surrendered 4,741 Class A common shares to the issuer at an imputed price of $3.74; no cash was received. The transaction is coded “F,” indicating share withholding rather than an open-market sale.
After the withholding, Shamsuddin directly owns 694,149 DH shares. No derivative securities were acquired or disposed of, and no additional insider transactions were reported. The surrendered shares equal roughly 0.7 % of her post-transaction holdings, suggesting minimal impact on insider ownership concentration or public float.